ARDD Program 2026

2026

October 1

Thursday · Canopy Hall, 3/F, David Rubenstein Treehouse at Harvard University

08:00–09:00

Breakfast

Breakfast and Registration

09:00–09:10

Opening

George Daley

Dean · Harvard Medical School

09:10–09:20

Chair Opening Introduction

Evelyne Bischof

Professor · Sheba Medical Center

Alex Zhavoronkov

CEO · Insilico Medicine

Vadim Gladyshev

Professor · Harvard Medical School

Morten Scheibye-Knudsen

Professor · University of Copenhagen

Jesse Poganik

Instructor · Harvard Medical School

09:20–09:30

Talk

Jamie Justice

Executive Vice President of the Health Domain · XPRIZE Healthspan

09:30–09:50

Talk

Policy & Regulatory Address

Special guest keynote

09:50–10:00

Talk

Clinical trials for aging, how ARPA-H PROSPR is building the train tracks to support a future industry

Andrew Brack

Program Manager, Proactive Health · ARPA-H

10:00–10:50

Panel

Matching Clinical Trials of Therapeutics & Regulatory Mandates

Andrew BrackModerator

Program Manager, Proactive Health · ARPA-H

10:50–11:20

Networking

Morning Networking Break

11:20–12:00

Panel

Clinical Trials in Diseases of Aging: From Evidence to New Therapeutics and Regulatory Pathways

Sebastien ThuaultModerator

Editor · Nature Medicine

Steven QuayPanelist

CEO · Atossa Therapeutics

Jill LeePanelist

Director, Regulatory Policy & Intelligence · Novo Nordisk

Calum MacRaePanelist

Professor · Mass General Brigham

Christoph WestphalPanelist

General Partner · Longwood Fund

Steve HorvathPanelist

Professor · UCLA

Brian NahedPanelist

Neurosurgical Oncologist · Mass General Brigham

12:00–13:00

Lunch

Lunch Break

13:00–14:00

Session

AI & Clinical Trials in Healthspan

Andrew ShinModerator

Senior Vice President of Strategy · Mass General Brigham

13:00–13:20

Talk

Elena Bonfiglioli

Regional Leader · Microsoft Health Futures

13:20–13:40

Talk

Wei-Wu He

CEO · Human Longevity, Inc.

13:40–14:00

Talk

Evelyne Bischof

Professor · Sheba Medical Center

14:00–15:00

Session

Healthspan in Leading Industries

Josh Joyner (TBC)Moderator

Editor · Forbes Health

14:00–14:20

Talk

Stephanie Manson-Brown

Head of Clinical Development & Scientific Innovation and Skincare R&D · AbbVie

14:20–14:40

Talk

Laure Crabbe-Vert

Senior Life Science Innovation Manager · LVMH Research

14:40–15:00

Talk

Philipp Gut

Adult Health Lead and Research Lead Healthy Longevity · Nestlé

15:00–15:30

Networking

Afternoon Networking Break and Poster Session

Poster session at One Milestone

15:30–16:30

Session

Pharma R&D and Productivity

Lisa MeltonModerator

Senior News Editor · Nature Biotechnology

15:30–15:50

Talk

Michael Li

Assistant Professor · Harvard Business School

15:50–16:10

Talk

Alexander Schuhmacher

Professor · Technische Hochschule Ingolstadt

16:10–16:30

Talk

Michael Ringel

COO · Life Biosciences

16:30–17:30

Session

Clinical Healthspan Trials and Practice

Barbara CheifetModerator

Chief Editor · Nature Biotechnology

16:30–16:50

Talk

Vishwa Deep Dixit

Professor · Yale School of Medicine

16:50–17:10

Talk

James Kirkland

Professor · Cedars-Sinai Medical Center

17:10–17:30

Talk

Nicole Sirotin

CEO · Institute for Healthier Living Abu Dhabi

17:30–18:10

Panel

From Healthspan Trials to Clinical Practice: Building the Path to Patient Access

Michael BassonModerator

Editor · Nature Medicine

David DodickPanelist

CMO/Professor · Atria Health Institute/Mayo Clinic

Sara BonnesPanelist

Professor · Mayo Clinic College of Medicine

Erwin TanPanelist

Senior Director · AARP

18:10–18:20

Closing Remarks

2026

October 2

Friday · Canopy Hall, 3/F, David Rubenstein Treehouse at Harvard University

08:00–09:00

Breakfast

Breakfast and Registration

09:00–09:15

Opening

Chair Opening Introduction

Alex Zhavoronkov

CEO · Insilico Medicine

Vadim Gladyshev

Professor · Harvard Medical School

Morten Scheibye-Knudsen

Professor · University of Copenhagen

Daniela Bakula

Professor · University of Copenhagen

Jesse Poganik

Instructor · Harvard Medical School

09:15–09:35

Talk

Reimagining Drug Discovery Through the Lens of Aging Biology

Fiona Marshall

President, Biomedical Research · Novartis

09:35–10:20

Panel

Pharma Chief Executive Panel

Alice ParkModerator

Senior Health Correspondent · TIME

Christophe WeberPanelist

Ex-CEO · Takeda

Elcin Barker ErgunPanelist

CEO · Menarini

Fiona MarshallPanelist

President, Biomedical Research · Novartis

Ariel FeldsteinPanelist

CSO, Internal Medicine · Pfizer

10:20–10:40

Talk

Alex Zhavoronkov

CEO · Insilico Medicine

10:40–11:00

Talk

Kevin Duffin

VP, Aging Research · Eli Lilly

11:00–11:30

Networking

Morning Networking Break and Group Photo

11:30–12:10

Panel

New Technology Partnering & Licensing

Alex PhilippidisModerator

Senior Business Editor · Genetic Engineering & Biotechnology News

Morten SogaardPanelist

SVP, Head of Astellas Innovation Lab · Astellas

Christopher AustinPanelist

SVP, R&D Technologies · GSK

Alex CogdillPanelist

Head of Strategic Initiatives, Global Business Development · Daiichi Sankyo

Vishnu SreshtPanelist

Director, Computational Chemistry and Machine Learning · Genentech

12:10–12:30

Talk

George Church

Professor · Harvard Medical School

12:30–13:30

Lunch

Lunch Break

13:30–13:50

Talk

B-

BioAge - Novartis joint presentation

13:50–14:10

Talk

Maxwell Biosciences

14:10–14:30

Talk

Biocytogen

14:30–14:50

Talk

Tony Wyss-Coray

Professor · Stanford University

14:50–15:30

Panel

Diseases as a Pathway to Longevity Therapeutics: Which age-related disease resembles aging most closely?

Barbara CheifetModerator

Chief Editor · Nature Biotechnology

Ruth GimenoPanelist

VP, Diabetes, Obesity & Cardiometabolic Research and Early Clinical Development · Eli Lilly

Ariel FeldsteinPanelist

CSO, Internal Medicine · Pfizer

Carine BoustanyPanelist

SVP, Global Head of Immunology and Respiratory Diseases · Boehringer Ingelheim

15:30–16:00

Networking

Afternoon Networking Break and Poster Session

Poster session at One Milestone. Ice cream station outside starting at 3:00 PM.

16:00–16:40

Panel

Early Stage Investor Panel

Garri ZmudzeModerator

Managing Partner · LongeVC

Arie BelldegrunPanelist

Co-Founder · Bellco Capital

Yan LeiPanelist

CEO · Synaro Capital

Gérôme GuiotPanelist

Strategic Projects Director · LVMH

Chuen Yan LeungPanelist

Partner, Healthcare Investment · Value Partners Group

Amol PawarPanelist

Executive Director · UBS

16:40–17:20

Panel

Full-Stack and Growth Stage Investor Panel

Patrick Temple-WestModerator

Journalist · Financial Times

Jim FlynnPanelist

Managing Partner · Deerfield

Alfredo ViegasPanelist

Managing Director · Oaktree Capital Management

Murali VenkatesanPanelist

Global Head of Danaher Ventures · Danaher

Carl GordonPanelist

Managing Partner · OrbiMed

Kan ChenPanelist

Partner · Qiming Venture Partners

17:20–17:40

Talk

Kirsten Seale

Scientist · TruDiagnostic

17:40–18:00

Talk

Marco Quarta

Co-Founder, CSO · Rubedo Life Sciences

18:00–18:20

Talk

Adiv Johnson

CSO · Tally Health

18:20–18:40

Talk

Matthew O’Connor

CEO · Cyclarity Therapeutics

19:00–21:00

Dinner

ARDD Gala Dinner (Invite Only)

Parallel forum at Cedar Grove, 2/F, David Rubenstein Treehouse at Harvard University · 09:00–17:30

Opening

9:00–9:10

Opening Remarks & Welcome

AI & Computational Design in Drug Discovery

9:10–9:30

Presenter 1

Yves Fomekong Nanfack

Head of ML · Takeda

9:30–9:50

Presenter 2

Alex Zhavoronkov

CEO · Insilico Medicine

9:50–10:10

Presenter 3

Kia Winslow

Director · BioAge

10:10–10:30

Presenter 4

Reproducibility-Aware AI for Drug Discovery: Purrsistence as a Service

Alex Voda

CEO · Cat Health Company

10:30–10:45

Coffee Break

Large Scale Datasets to Feed future AIs

10:45–11:05

Presenter 5

Proteomic Clocks for Target Nomination

Jon Gootenberg

Professor · Harvard

11:05–11:25

Presenter 6

Retro

11:25–11:45

Presenter 7

Biomedical Mega Projects for Data Collection in Longevity

Max Unfried

Scientist · National University of Singapore

11:45–12:30

Panel Discussion / Open Q&A

What does AI in Longevity Biotech really need?

Anna Skaya

General Partner · AniVC

12:30–13:30

Lunch

13:30–13:40

Opening Remarks & Welcome

Targeting Neurodegeneration with AI

13:40–14:00

Presenter 8

AI4Cure-AD platform for Alzheimer's disease drug development

Feixiong Cheng

Director, Genome Center · Cleveland Clinic

14:00–14:20

Presenter 9

DeepDrugX for Alzheimer's Disease Drug Discovery,

Jacqueline LAM

Scholar · University of Cambridge

14:20–14:40

Presenter 10

LLMs to Flip the Script on Neuroimmune Aging Targets

Gerald Lushington

Expert Team Lead · SpaceX/Qnapsyn Biosciences, Inc.

14:40–15:20

Panel Discussion / Open Q&A

Beyond Decline: Next-Generation Targets in Neuroimmune Aging

Derek M. Huffman

Professor, Molecular Pharmacology & Medicine · Albert Einstein College of Medicine

15:20–15:35

Coffee Break

AI for Systems Immunology & Immune Aging

15:35–15:55

Presenter 11

Derya Unutmaz

Professor · Jackson Lab

15:55–16:15

Presenter 12

David Furman

Professor · Buck Institute

16:15–16:35

Presenter 13

AI Antibody Design

Debora Marks

Professor · Harvard

16:35–17:20

Panel Discussion / Open Q&A

Andrea Cipriano

Executive Committee member · Biomarkers of Aging consortium - Stanford University School of Medicine - Eli Lilly

17:20–17:30

Closing Remarks

2026

October 3

Saturday · Canopy Hall, 3/F, David Rubenstein Treehouse at Harvard University

08:00–09:00

Breakfast

Breakfast and Registration

09:00–17:30

Pet and Animal Longevity Forum and Virtual Cell in Time Forum at Cedar Grove

Parallel track

09:00–09:15

Opening

Chair Opening Introduction

Alex Zhavoronkov

CEO · Insilico Medicine

Vadim Gladyshev

Professor · Harvard Medical School

Morten Scheibye-Knudsen

Professor · University of Copenhagen

Daniela Bakula

Professor · University of Copenhagen

Jesse Poganik

Instructor · Harvard Medical School

09:15–09:35

Talk

Jim O'Neill (Tentative)

09:35–09:55

Talk

Vadim Gladyshev

Professor · Harvard Medical School

09:55–10:15

Talk

Mark Cobbold

SVP, IO Discovery & Cell Therapy Oncology · AstraZeneca

10:15–11:00

Panel

Search & Evaluation Strategies for Longevity Therapeutics

Lisa MeltonModerator

Senior News Editor · Nature Biotechnology

Thomas MarronPanelist

AVP, Emerging Innovation and Strategic Growth · Eli Lilly

Kaivan KhavandiPanelist

SVP & Global Head, Respiratory, Immunology & Inflammation R&D · GSK

Tala FakhouriPanelist

Chief AI & Regulatory Strategy Officer · Parexel

11:00–11:30

Networking

Morning Networking Break and Group Photo

11:30–12:10

Panel

Metabolic health and longevity symposium by Nestlé Research

12:10–12:30

Talk

Holistic approach to aging population

Alejandro Aguayo-Orozco

Senior Scientific Director, Diabetes Insights · Novo Nordisk

12:30–13:30

Lunch

Lunch Break

13:30–14:10

Panel

Aging research in pharma

Sebastian Thuault (TBC)Moderator

Editor · Nature Aging

Sophie Lemire-BrachatPanelist

Executive Director, Head of Translational and Data Science, Diseases of Aging and Regenerative Medicine · Novartis

Maria DermitPanelist

Scientist · Novo Nordisk

Björn TackenbergPanelist

Head of Integrative Neuroscience · Roche

William MairPanelist

Professor of Molecular Metabolism · Harvard University

14:10–14:50

Panel

Therapeutic Assets & Licensing (Late Stage)

Cailin McGurkModerator

Managing Director · Morgan Stanley

Monika VnukPanelist

SVP, Global Head of Partnering and Business Development · Sanofi

Phil McGurkPanelist

SVP, Head of Global Business Development · Takeda

14:50–15:10

Talk

Martin Borch Jensen

Co-Founder, CSO · Gordian Biotechnology

15:10–15:30

Talk

Cambrian Bio

15:30–16:00

Networking

Afternoon Networking Break and Poster Session

Poster session at One Milestone. Ice cream station outside starting at 3:00 PM.

16:00–16:40

Panel

Therapeutic Assets & Licensing (Early Stage)

Brianna StubbsModerator

Research Assistant Professor & Director of Translational Science · Buck Institute for Research on Aging

Jonathan LeviPanelist

Senior Director, R&D Strategy · AstraZeneca

Xingli WangPanelist

Global Partner · Fosun Pharma

Claris MunksgaardPanelist

Director, Business Development and Licensing · EMD Serono/Merck

Nikolaj Kulahin Roed (TBC)Panelist

Global Project Leader · Novo Nordisk

16:40–17:00

Talk

Johan Luthman

EVP, R&D · Lundbeck

17:00–17:20

Talk

Tolerance Bio

17:20–17:40

Talk

Gordan Lauc

Professor · University of Zagreb

17:40–18:00

Talk

Brian Bodemann

CEO · ARTAN Bio

18:00–18:20

Talk

David Sinclair

Professor · Harvard Medical School

18:20–18:40

Talk

Morten Scheibye-Knudsen

Professor · University of Copenhagen

18:40–19:00